Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2025 May;97(5):e70363.
doi: 10.1002/jmv.70363.

Performance of Subgenomic RT-PCR for Predicting SARS-CoV-2 Infectivity Compared to Genomic RT-PCR and Culture Isolation

Célia Sentis  1 , Delphine Parraud  1   2 , Geneviève Billaud  1 , Martine Valette  1 , Maude Bouscambert-Duchamp  1 , Bruno Lina  1   2 , Florence Morfin  1   2 , Alexandre Gaymard  1   2
Affiliations
Comparative Study

Performance of Subgenomic RT-PCR for Predicting SARS-CoV-2 Infectivity Compared to Genomic RT-PCR and Culture Isolation

Célia Sentis et al. J Med Virol. 2025 May.

Abstract

SARS-CoV-2 clinical samples can be detected as positive for a long period of time using real-time RT-PCR, even when patients are no longer infectious. Viral culture is the gold standard for assessing a patient's infectivity, but it is a time-consuming technique and lacks sensitivity. SARS-CoV-2 subgenomic RNA (sgRNA) detection has been used as a proxy for assessing the infectivity but only a limited number of studies have described its use in vitro and in clinical samples. This study aimed to evaluate the correlation between results from viral culture, genomic RT-PCR (gRT-PCR), and subgenomic RT-PCR (sgRT-PCR) during in vitro infection and in clinical samples. In vitro viral replication kinetics showed that both genomic RNA (gRNA) and subgenomic RNA (sgRNA) levels remained stable up to 21 days in the absence of replication-competent virus. Using clinical samples, sgRNA was detected in 87.5% of culture-positive samples, demonstrating better performances than gRT-PCR (Positive predictive value (PPV) 93.3% and Negative predictive value (NPV) of 87.5%) and an almost perfect agreement with culture results (Cohen κ = 0.81 [95% CI: 0.66-0.95]). These findings suggest that testing for sgRNA and/or using a gRNA Ct cut-off of 21.2 could be used as a proxy to determine the presence of SARS-CoV-2 replication-competent virus.

Keywords: SARS‐CoV‐2; culture; infectivity evaluation; subgenomic RNA; viral isolation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Kinetics of SARS‐CoV‐2 replication on Vero cells according to variant and MOI. (A) Alpha, (B) Omicron, (C) Delta, (D) MOI 10− 1, (E) MOI 10‐2. Of note, the Y axis (CIT50) is plotted inversely to have a better visualization of the CIT50 peak. CIT50, cell index time 50; dpi, day post infection; MOI, multiplicity of infection.
Figure 2
Figure 2
Kinetics of SARS‐CoV‐2 on Vero cells: comparison of gRT‐PCR, sgRT‐PCR, and RTCA. (A) Alpha, (B) Delta, (C) Omicron. Of note, the left and right Y axes are plotted inversely. CIT50, cell index time 50; dpi, day post infection; gRT‐PCR, genomic RT‐PCR; RTCA, real time cellular assay; sgRT‐PCR, subgenomic RT‐PCR.
Figure 3
Figure 3
Culture‐isolation and subgenomic results according to genomic RT‐PCR Ct. (A) Culture results, (B) Subgenomic results. Statistical analysis was performed using Student t‐tests. **** = < 0.001. Red dotted line: cut‐off determined by ROC analysis.
Figure 4
Figure 4
Correlation between sgRT‐PCR Ct and gRT PCR Ct. Blue dotted line: cut‐off determined by ROC analysis. gRT‐PCR, genomic RT‐PCR; sgRT‐PCR, subgenomic RT‐PCR.
See this image and copyright information in PMC

References

    1. Li Q., Guan X., Wu P., et al., “Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia,” New England Journal of Medicine 382, no. 13 (2020): 1199–1207, 10.1056/NEJMoa2001316. - DOI - PMC - PubMed
    1. Aranha C., Patel V., Bhor V., and Gogoi D., “Cycle Threshold Values in RT‐PCR to Determine Dynamics of SARS‐CoV‐2 Viral Load: An Approach to Reduce the Isolation Period for COVID‐19 Patients,” Journal of Medical Virology 93, no. 12 (2021): 6794–6797, 10.1002/jmv.27206. - DOI - PMC - PubMed
    1. Perera R. A. P. M., Tso E., Tsang O. T. Y., et al., “SARS‐CoV‐2 Virus Culture and Subgenomic RNA for Respiratory Specimens From Patients With Mild Coronavirus Disease,” Emerging Infectious Diseases 26, no. 11 (2020): 2701–2704, 10.3201/eid2611.203219. - DOI - PMC - PubMed
    1. Santos Bravo M., Berengua C., Marín P., et al., “Viral Culture Confirmed SARS‐CoV‐2 Subgenomic RNA Value as a Good Surrogate Marker of Infectivity,” Journal of Clinical Microbiology 60, no. 1 (2022): e01609‐21, 10.1128/JCM.01609-21. - DOI - PMC - PubMed
    1. Qutub M., Aldabbagh Y., Mehdawi F., et al., “Duration of Viable SARS‐CoV‐2 Shedding From Respiratory Tract in Different Human Hosts and Its Impact on Isolation Discontinuation Polices Revision; a Narrative Review,” Clinical Infection in Practice 13 (2022): 100140, 10.1016/j.clinpr.2022.100140. - DOI - PMC - PubMed

Publication types

MeSH terms